The deadline for abstract submission is Monday, October 11, 2010. All submissions should not exceed 450 words.
The Scientific Committee requests that authors submit their abstracts electronically via the Conference website. To submit electronically please click on the button at the bottom of the page and follow the step-by-step directions, which will enable you to upload the file containing your abstract from the computer system that you are using to access this website. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.
**Special Note: Requirement of Disclosure of New Compound Structures at HIV DART 2010**
It is required that presentation of any new, previously unpublished compound at HIV DART 2010 includes disclosure of the chemical structure.
The online abstract submission process will require affirmation of the authors’ intention to disclose said chemical structure(s). The purpose of this rule is to ensure presentation of sufficient data to allow for meaningful scientific discourse relevant to new developments in the field of drug discovery, and the rule is based on established practices of other similar international conferences, e.g. CROI.
Authors who believe there is a compelling reason to be exempted from this rule will have an opportunity to present their rationale for nondisclosure to the Program Committee during the course of online abstract submission. The Program Committee will take the arguments into consideration during the abstract review process, but it should be noted that exemptions will be granted only rarely.
Non-disclosure of compound structure(s) without prior permission of the Program Committee may result in loss of HIV DART presentation privileges for up to two years for all authors on the abstract in question.
Abstract Format
The body of the uploaded abstract submission should not exceed 450 words; this limit excludes the title, authors and affiliations.
Clearly define all concepts and abbreviations at first use. If English is not your primary language, attempt to have your abstract reviewed by a native English speaker. To be acceptable, abstracts shall contain a concise statement of the research. It is recommended that the author follow the structured format below:
Title (not included in 450 word limit)
Use a short and concise title that indicates the content of the abstract. Capitalize the first letter of each word except prepositions, articles, and species names. Species names should be spelled out at first use. Italicize scientific names of organisms (example: Staphylococcus aureus). For therapeutic agents, only generic names may be used (no trade names are permitted in abstract titles).
Authors/Affiliations (not included in 450 word limit)
Authors' names should be entered using initial(s) for the first and middle names followed by the full last name, with presenting author underlined (e.g. AN Author1, AN Author2 and AN Author3).
All author affiliations should be entered as follows:
1 University of London, London, UK; 2 University of Frankfurt, Frankfurt, Germany; and 3 University of Paris, Paris, France.
Background
State the problem under investigation or a hypothesis. For therapeutic agents, only generic names may be used (no trade names are permitted). No figures or tables are allowed.
Methods
Explain the experimental methods used. For therapeutic agents, only generic names may be used (no trade names are permitted). No figures or tables are allowed.
Results
List the essential results obtained in summary form, with enough quantitative data to permit evaluation by reviewers. For therapeutic agents, only generic names may be used (no trade names are permitted). No figures or tables are allowed.
Conclusion
Summarize the findings. It is unacceptable to use statements such as "the results will be discussed". For therapeutic agents, only generic names may be used (no trade names are permitted). Simple figures or tables are allowed.
Additional Abstract Information
In addition to the uploaded abstract, the following additional information will be collected on the abstract submission form:
Contact Information
The presenting author must enter a complete address to ensure that correspondence arrives promptly and easily.
Preferred Form of Presentation
Poster, Oral, Either
Abstract Category
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Organizing Committee reserves the right to reassign your abstract to a more appropriate category.
• Antiretroviral Targets
• Pharmacology, Toxicology and Drug Metabolism
• Novel Monitoring and Diagnostic Approaches
• Novel Therapeutic Agents and Immunological Approaches
• Novel Drug Delivery Methods
• Preventing Transmission: Microbicides and Other Approaches
• Drug Resistance and Modeling
• Pathogenesis and Animal Models
• HIV Reservoirs, Persistence and Eradication
• Treatment Strategies in Developing Countries
• Special Populations
• Consequences of Long-term HAART
• HIV/Hepatitis and Other Co-infections
Abstract Title (should be the same as in the uploaded abstract)
Use a short and concise title that indicates the content of the abstract. Capitalize the first letter of each word except prepositions, articles, and species names. Species names should be spelled out at first use. Italicize scientific names of organisms (example: Staphylococcus aureus). For therapeutic agents, only generic names may be used (no trade names are permitted in abstract titles).
Sample Abstract
To view a sample abstract, click here.
The sample form is an Adobe Acrobat document. If your computer cannot read the sample, please click here to download Adobe's free Acrobat Reader.
Abstract Notifications
Notifications of acceptance and format of presentation (oral or poster presentation) will be announced on October 18, 2010. It is the responsibility of the corresponding/presenting author to inform all co-authors of the disposition status. If you have not received notification by October 20, 2010, please call +1 (781) 648-1933.
If an abstract is accepted, one author is required to register for the conference and present the paper as scheduled. Guidelines for preparing your poster presentations will be sent if your abstract is accepted. It is suggested that all accepted posters be set up prior to start of sessions on
December 8, 2010.
Published Abstract Book
Accepted abstracts will be standardized in font and presentation. Abstracts will NOT be edited in any way. Thus, any error that appears in the submitted abstract will appear in the printed abstract.
Subject to availability, copies of the Abstract Book will be available for sale after the Conference. Please contact the Conference Secretariat.
|
